Knowledge hub

Business

News

New Publication on Decoding Phenotypic Screening: A Collaborative Effort with Janssen Pharmaceutica and Jagiellonian University

Ardigen Appoints New CCO to Accelerate Growth Plans and Become the Top AI CRO Worldwide
Ardigen and Selvita Now Offer Joint Cell Painting Services
New Paper Released by Ardigen and Collaborators: Advances in AI – Powered Histological Evaluation of Crohn’s Disease and Ulcerative Colitis
Ardigen Collaborates on Breakthrough in TCR Therapy Advancements
Ardigen CEO Janusz Homa Recognized Among AI Sector Leaders by Forbes Polska
Ardigen and DKFZ Research Groups Collaborate to Evaluate the TCR-based Therapies (TCR-Ts)
Mariola Fotin-Mleczek, PhD, Has Joined Ardigen’s Scientific Board
Ardigen supports JUMP-CP Consortium – The World’s Largest Public Cell Painting Dataset
News

Agnieszka Blum, MD, PhD, Promoted to the Ardigen Management Board

Prof. Dr. med. Michael Schmitt, MHBA in Ardigen’s Scientific Board
Łukasz Dutkiewicz, PhD Welcomed in Ardigen as a Business Development Director
Discover Our Gene Regulation Platform
Ardigen – New Corporate Identity
Prof. Olivera Finn joined Ardigen’s Scientific Board